ALT-801

· Altor BioScience

Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for ALT-801, covering 2013-07-15 to 2025-06-24. Get the full timeline:

Most recent: Clinical Trial Update: ALT-801 in Overweight and Obese Subjects With Type 2 Diabetes Mellitus (T2DM) [Phase 1]